These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 16859688

  • 1. Bone marrow transplantation improves outcome in a mouse model of congenital muscular dystrophy.
    Hagiwara H, Ohsawa Y, Asakura S, Murakami T, Teshima T, Sunada Y.
    FEBS Lett; 2006 Aug 07; 580(18):4463-8. PubMed ID: 16859688
    [Abstract] [Full Text] [Related]

  • 2. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.
    Vilquin JT, Kennel PF, Paturneau-Jouas M, Chapdelaine P, Boissel N, Delaère P, Tremblay JP, Scherman D, Fiszman MY, Schwartz K.
    Gene Ther; 2001 Jul 07; 8(14):1097-107. PubMed ID: 11526457
    [Abstract] [Full Text] [Related]

  • 3. [Dystrophin expression and pathology of diaphragm muscles of mdx mice after xenogenic bone marrow stem cell transplantation].
    Zhang YN, Zhang C, Yu MJ, Wang SH, Li MS, Huang H, Xiong F, Feng SW, Liu TY, Lu XL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 07; 26(1):53-8. PubMed ID: 16495176
    [Abstract] [Full Text] [Related]

  • 4. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E, Pennington C, Isales CM, Hamrick MW.
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep 07; 286(1):814-22. PubMed ID: 16078270
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
    Rooney JE, Welser JV, Dechert MA, Flintoff-Dye NL, Kaufman SJ, Burkin DJ.
    J Cell Sci; 2006 Jun 01; 119(Pt 11):2185-95. PubMed ID: 16684813
    [Abstract] [Full Text] [Related]

  • 9. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
    Vilquin JT, Guérette B, Puymirat J, Yaffe D, Tomé FM, Fardeau M, Fiszman M, Schwartz K, Tremblay JP.
    Gene Ther; 1999 May 01; 6(5):792-800. PubMed ID: 10505103
    [Abstract] [Full Text] [Related]

  • 10. A comparative freeze-fracture study of plasma membrane of dystrophic skeletal muscles in dy/dy mice with merosin (laminin 2) deficiency and mdx mice with dystrophin deficiency.
    Shibuya S, Wakayama Y, Oniki H, Kojima H, Saito M, Etou T, Nonaka I.
    Neuropathol Appl Neurobiol; 1997 Apr 01; 23(2):123-31. PubMed ID: 9160897
    [Abstract] [Full Text] [Related]

  • 11. Exercise improves the success of myoblast transplantation in mdx mice.
    Bouchentouf M, Benabdallah BF, Mills P, Tremblay JP.
    Neuromuscul Disord; 2006 Aug 01; 16(8):518-29. PubMed ID: 16919954
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.
    Girgenrath M, Dominov JA, Kostek CA, Miller JB.
    J Clin Invest; 2004 Dec 01; 114(11):1635-9. PubMed ID: 15578095
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
    Gawlik KI, Holmberg J, Durbeej M.
    Am J Pathol; 2014 Mar 01; 184(3):740-52. PubMed ID: 24393714
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Dystrophin expression in mdx mice after bone marrow stem cells transplantation].
    Feng SW, Zhang C, Yao XL, Yu MJ, Li JL, Chen SL, Liu TY, Lu XL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr 01; 28(2):178-81. PubMed ID: 16733899
    [Abstract] [Full Text] [Related]

  • 18. Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate.
    Dadush O, Aga-Mizrachi S, Ettinger K, Tabakman R, Elbaz M, Fellig Y, Yanay N, Nevo Y.
    Neuromuscul Disord; 2010 Apr 01; 20(4):267-72. PubMed ID: 20304648
    [Abstract] [Full Text] [Related]

  • 19. Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse.
    Elbaz M, Yanay N, Aga-Mizrachi S, Brunschwig Z, Kassis I, Ettinger K, Barak V, Nevo Y.
    Ann Neurol; 2012 May 01; 71(5):699-708. PubMed ID: 22522482
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.